Biology Reference
In-Depth Information
Muller F, Aukrust P, Nordùy I, Frùland SS. 1998. Possible role of interleukin-10 (IL-10) and CD40
ligand expression in the pathogenesis of hypergammaglobulinemia in human immunode®ciency
virus infection: modulation of IL-10 and Ig production after intravenous Ig infusion. Blood 92:
3721±3729.
Murray HW, Rubin BY, Masur H, Roberts RB. 1984. Impaired production of lymphokines and
immune (gamma) interferon in the acquired immunode®ciency syndrome. N Engl J Med 310:
883±889.
Muzio M, Polentarutti N, Sironi M, Poli G, De Gioia L, Introna M, Mantovani A, Colotta F.
1995. Cloning and characterization of a new isoform of the interleukin-1 (IL-1) receptor antag-
onist. J Exp Med 182: 623±628.
Nath A, Conant K, Chen P, Scott C, Major EO. 1999. Transient exposure to HIV-1 Tat protein
results in cytokine production in macrophages and astrocytes. A hit and run phenomenon. J Biol
Chem 274: 17098±17102.
O'Garra A, Murphy K. 1996. Role of cytokines in development of Th1 and Th2 cells. Chem Im-
munol 63: 1±13.
O'Garra A, Steinman L, Gijbels K. 1997. CD4
T-cell subsets in autoimmunity. Curr Opin Im-
munol 9: 872±883.
Oliva A, Kinter AL, Vaccarezza M, Rubbert A, Catanzaro A, Moir S, Monaco J, Ehler L, Mizell
S, Jackson R, Li Y, Romano JW, Fauci AS. 1998. Natural killer cells from human im-
munode®ciency virus (HIV)-infected individuals are an important source of CC-chemokines and
suppress HIV-1 entry and replication in vitro. J Clin Invest 102: 223±231.
Orenstein JM, Fox C, Wahl SM. 1997. Macrophages as a source of HIV during opportunistic in-
fections. Science 276: 1857±1861.
Pal R, Garzino-Demo A, Markham PD, Burns J, Brown M, Gallo RC, DeVico AL. 1997. In-
hibition of HIV-1 infection by the beta-chemokine MDC [see comments]. Science 278: 695±698.
Paul WE. 1989. Pleiotropy and redundancy: T cell-derived lymphokines in the immune response.
Cell 57: 521±524.
Paul WE, Seder RA. 1994. Lymphocyte responses and cytokines. Cell 76: 241±251.
Pericle F, Pinto LA, Hicks S, Kirken RA, Sconocchia G, Rusnak J, Dolan MJ, Shearer GM, Segal
DM. 1998. HIV-1 infection induces a selective reduction in STAT5 protein expression. J Im-
munol 160: 28±31.
Poli G, Orenstein JM, Kinter A, Folks TM, Fauci AS. 1989. Interferon-alpha but not AZT sup-
presses HIV expression in chronically infected cell lines. Science 244: 575±577.
Poli G, Bressler P, Kinter A, Duh E, Timmer WC, Rabson A, Justement JS, Stanley S, Fauci
AS. 1990. Interleukin 6 induces human immunode®ciency virus expression in infected mono-
cytic cells alone and in synergy with tumor necrosis factor alpha by transcriptional and post-
transcriptional mechanisms. J Exp Med 172: 151±158.
Poli G, Kinter AL, Justement JS, Bressler P, Kehrl JH, Fauci AS. 1991. Transforming growth fac-
tor beta suppresses human immunode®ciency virus expression and replication in infected cells of
the monocyte/macrophage lineage. J Exp Med 173: 589±597.
Poli G, Kinter AL, Justement JS, Bressler P, Kehrl JH, Fauci AS. 1992. Retinoic acid mimics
transforming growth factor beta in the regulation of human immunode®ciency virus expression
in monocytic cells. Proc Natl Acad Sci USA 89: 2689±2693.
Poli G, Biswas P, Fauci AS. 1994a. Interferons in the pathogenesis and treatment of human im-
munode®ciency virus infection. Antiviral Res 24: 221±233.
Poli G, Kinter AL, Fauci AS. 1994b. Interleukin 1 induces expression of the human immuno-
de®ciency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition
of inductive e¨ects by the interleukin 1 receptor antagonist. Proc Natl Acad Sci USA 91: 108±112.
Poon B, Grovit-Ferbas K, Stewart SA, Chen ISY. 1998. Cell cycle arrest by Vpr in HIV-1 virions
and insensitivity to antiretroviral agents. Science 281: 266±269.
